Profilo
Christina Cameron is currently Director-Investor Relations at Medicago, Inc., Vice President-Investor Relations at Antibe Therapeutics, Inc., and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
from 2019 to present.
Formerly, Ms. Cameron was an Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026.
Education includes an undergraduate degree from Wilfrid Laurier University.
Posizioni attive di Christina Cameron
| Società | Posizione | Inizio |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | - |
| MEDICENNA THERAPEUTICS CORP. | Contatto Relazioni con gli Investitori | 01/02/2019 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Christina Cameron
| Società | Posizione | Fine |
|---|
Formazione di Christina Cameron
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















